HRP20000600A2 - Benzofurylpyrone derivatives - Google Patents

Benzofurylpyrone derivatives Download PDF

Info

Publication number
HRP20000600A2
HRP20000600A2 HR20000600A HRP20000600A HRP20000600A2 HR P20000600 A2 HRP20000600 A2 HR P20000600A2 HR 20000600 A HR20000600 A HR 20000600A HR P20000600 A HRP20000600 A HR P20000600A HR P20000600 A2 HRP20000600 A2 HR P20000600A2
Authority
HR
Croatia
Prior art keywords
group
carbon atoms
pyran
denotes
dimethyl
Prior art date
Application number
HR20000600A
Other languages
English (en)
Croatian (hr)
Inventor
Yoshimitsu Naniwa
Hiroshi Imai
Tomohide Ida
Emiko Muratani
Kazuo Kitai
Yoshinori Sugimoto
Tomomi Kosugi
Akiko Takeuchi
Kunihito Watanabe
Takami Tomiyama
Tomio Takeuchi
Masa Hamada
Original Assignee
Teijin Ltd
Microbial Chem Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd, Microbial Chem Res Found filed Critical Teijin Ltd
Publication of HRP20000600A2 publication Critical patent/HRP20000600A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Furan Compounds (AREA)
  • Luminescent Compositions (AREA)
HR20000600A 1998-03-12 2000-09-12 Benzofurylpyrone derivatives HRP20000600A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6135698 1998-03-12
PCT/JP1999/001225 WO1999046262A1 (fr) 1998-03-12 1999-03-12 Derives de benzofurylpyrone

Publications (1)

Publication Number Publication Date
HRP20000600A2 true HRP20000600A2 (en) 2001-06-30

Family

ID=13168805

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000600A HRP20000600A2 (en) 1998-03-12 2000-09-12 Benzofurylpyrone derivatives

Country Status (25)

Country Link
US (2) US6589984B1 (zh)
EP (1) EP1063235B1 (zh)
JP (1) JP3922884B2 (zh)
KR (1) KR100595332B1 (zh)
CN (1) CN1170827C (zh)
AT (1) ATE266659T1 (zh)
AU (1) AU756965B2 (zh)
BG (1) BG104761A (zh)
BR (1) BR9908706A (zh)
CA (1) CA2323456A1 (zh)
DE (1) DE69917237T2 (zh)
EE (1) EE200000504A (zh)
HR (1) HRP20000600A2 (zh)
HU (1) HUP0101381A3 (zh)
ID (1) ID27511A (zh)
IL (1) IL138279A0 (zh)
IS (1) IS5617A (zh)
NO (1) NO20004517D0 (zh)
NZ (1) NZ506802A (zh)
PL (1) PL343419A1 (zh)
RU (1) RU2199536C2 (zh)
SK (1) SK13412000A3 (zh)
TR (1) TR200002642T2 (zh)
UA (1) UA58587C2 (zh)
WO (1) WO1999046262A1 (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1170827C (zh) * 1998-03-12 2004-10-13 帝人株式会社 苯并呋喃基吡喃酮衍生物
AU2001288432A1 (en) 2000-09-01 2002-03-22 Icos Corporation Materials and methods to potentiate cancer treatment
DE10115408A1 (de) * 2001-03-29 2002-10-02 Bayer Ag Benzofuran-Derivate
AU2003209990B8 (en) * 2002-02-25 2008-10-30 Kudos Pharmaceuticals Ltd Pyranones useful as ATM inhibitors
DE10314610A1 (de) 2003-04-01 2004-11-04 Aventis Pharma Deutschland Gmbh Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
BRPI0715160A2 (pt) 2006-08-08 2013-06-11 Sanofi Aventis imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007054497B3 (de) * 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
FR2929276B1 (fr) * 2008-04-01 2010-04-23 Servier Lab Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
US8785608B2 (en) 2009-08-26 2014-07-22 Sanofi Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120058A1 (de) 2011-03-08 2012-09-13 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8809324B2 (en) 2011-03-08 2014-08-19 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683698B1 (de) 2011-03-08 2017-10-04 Sanofi Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
DE102014214016A1 (de) 2014-07-18 2015-11-05 Deutsches Zentrum für Luft- und Raumfahrt e.V. Leichtbaustruktur und Verfahren zur Herstellung einer Leichtbaustruktur
US11433047B2 (en) * 2015-10-09 2022-09-06 Neurotheryx Canada Ltd. Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668803A (en) * 1984-05-10 1987-05-26 Atlantic Richfield Company Benzafuran derivatives
DE4308451A1 (de) 1992-09-10 1994-04-14 Bayer Ag 3-Aryl-pyron-Derivate
ZA938019B (en) 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
US5808062A (en) 1993-11-19 1998-09-15 Warner-Lambert Company Pyrone derivatives as protease inhibitors and antiviral agents
CN1170827C (zh) * 1998-03-12 2004-10-13 帝人株式会社 苯并呋喃基吡喃酮衍生物

Also Published As

Publication number Publication date
IS5617A (is) 2000-09-08
TR200002642T2 (tr) 2001-01-22
HUP0101381A2 (hu) 2002-05-29
KR20010041776A (ko) 2001-05-25
AU756965B2 (en) 2003-01-30
US6589984B1 (en) 2003-07-08
EE200000504A (et) 2002-02-15
CA2323456A1 (en) 1999-09-16
DE69917237T2 (de) 2005-05-04
UA58587C2 (uk) 2003-08-15
EP1063235B1 (en) 2004-05-12
BR9908706A (pt) 2000-11-21
RU2199536C2 (ru) 2003-02-27
BG104761A (en) 2001-08-31
WO1999046262A1 (fr) 1999-09-16
JP3922884B2 (ja) 2007-05-30
CN1299359A (zh) 2001-06-13
SK13412000A3 (sk) 2001-04-09
DE69917237D1 (de) 2004-06-17
AU3277399A (en) 1999-09-27
ID27511A (id) 2001-04-12
NZ506802A (en) 2002-11-26
NO20004517L (no) 2000-09-11
CN1170827C (zh) 2004-10-13
KR100595332B1 (ko) 2006-07-03
ATE266659T1 (de) 2004-05-15
HUP0101381A3 (en) 2002-06-28
IL138279A0 (en) 2001-10-31
US20030186976A1 (en) 2003-10-02
EP1063235A1 (en) 2000-12-27
NO20004517D0 (no) 2000-09-11
PL343419A1 (en) 2001-08-13
EP1063235A4 (en) 2003-01-07

Similar Documents

Publication Publication Date Title
HRP20000600A2 (en) Benzofurylpyrone derivatives
JP6741825B2 (ja) Dna−pk阻害剤
JP2024012558A (ja) Sumo活性化酵素の阻害薬として有用なヘテロアリール化合物
US9205077B2 (en) 2-alkoxy-substituted dicyanopyridines and their use
JP6993357B2 (ja) Apjアゴニストとしての6-ヒドロキシ-5-(フェニル/ヘテロアリールスルホニル)ピリミジン-4(1h)-オン
ES2590917T3 (es) Dicianopiridinas sustituidas con heteroarilo y su uso para el tratamiento de enfermedades cardiovasculares
KR101829290B1 (ko) Gpr120 효능제로서의 바이아릴 유도체
KR101559326B1 (ko) c-fms 키나아제의 억제제
EP1107973B1 (en) NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
AU2016340264A1 (en) 2,4-dihydroxy-nicotinamides as APJ agonists
KR20120049940A (ko) 키나제 억제제로서의 헤테로아릴 화합물
KR20120092586A (ko) 증식성 질환의 치료에 유용한 비피리딘
KR20230124926A (ko) Trpm3 매개 장애를 치료하기 위한 헤테로사이클 유도체
JP2000128878A (ja) ベンゾフリル−α−ピリドン誘導体
KR102607510B1 (ko) 무스카린 m1 수용체 양성 알로스테릭 조절제로서의 피롤로-피리다진 유도체
CN101094827B (zh) 具有两个或更多取代基的苯化合物
MXPA00008781A (en) Benzofurylpyrone derivatives
CZ20003191A3 (cs) Deriváty benzofuryl-alfa-pyronu, farmaceutické prostředky, synergisté, inhibitory a činidla
WO2022152852A1 (en) Antagonists of mrgx2

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn